BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
ScienceWhy Drug Companies Are Rushing to Market Ketamine MedicinesBusinessEU agency warns websites may need to be taken offline as PHP prepares patches for vulnerabilitiesBusinessMalaysia bans civil servants from using mapping app Waze, citing links to IsraelBusinessAt Close of Business podcast October 21 2026BusinessOpinion: Pivot a prelude to startup success
Science/Source-attributed reporting
Science DESK

Why Drug Companies Are Rushing to Market Ketamine Medicines

Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.

Published Oct 20, 2026 · 3:30 PMOriginal source: NYT > Science9 reads
Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.
ORIGINAL SOURCE

NYT > Science

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗
RELATED COVERAGE

More from this desk.

BAGANBAZAR GRAPHSource-attributed newsSCIENCE desk
Science

U.S. antipoverty tax credit expansion may have unintended costs for children's development

As part of U.S. welfare reforms in the 1990s to provide adequate financial support to low-income families while avoiding disincentivizing work, policymakers expanded the Earned Income Tax Credit (EITC). This change encouraged people to work more by giving greater benefits with greater earned income, and single mothers faced stronger incentives to enter the workforce than married mothers.

Original sourcePhys.org - latest science and technology news stories